medigraphic.com
SPANISH

Gaceta Médica de México

ISSN 0016-3813 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2011, Number 3

<< Back Next >>

Gac Med Mex 2011; 147 (3)

Assesment of moisturizing creams avilable in México

Hernández-Barrera NR, Moncada B, Navarrete-Solís J, Fuentes-Ahumada C, Torres-Álvarez B, Castanedo-Cázares JP, Cano-Ríos P
Full text How to cite this article

Language: Spanish
References: 12
Page: 270-274
PDF size: 90.98 Kb.


Key words:

Moisturizer cream, Cutaneous hydration, Transepidermal water loss, Xerosis.

ABSTRACT

There is a broad diversity of moisturizers for the treatment of dry skin; however, we do not know their real effectiveness. The objective here was to evaluate different products through their capacity to increase the epidermal hydration level (EHL) and to reduce the transepidermal water loss (TEWL). Materials and methods: We evaluated twenty moisturizers in sixteen individuals. The analysis was made on volar forearm and basal measurements were made for EHL and TWEL with the later application of 8 gm of each moisturizer on a 2 cm2 area. Results: For the EHL we found significant differences among the products (p ‹ 0.0001), but only 35% (n = 7) of the moisturizers registered ascending levels of hydration in the course of measurements. The variance analysis for TEWL also was significant (p ‹ 0.0001). Conclusions: In the short term only a few products induced a significant change in EHL. This study demonstrates the necessity to obtain objective information in order to avoid false publicity claims that may erroneously influence our prescription habits.


REFERENCES

  1. Lodén M. Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders. Am J Clin Dermatol. 2003;4(11);771-88.

  2. Kraft JN, Lynde CW. Moisturizers. What they are and a practical approach to product selection. Skin Therapy Letter. 2005;10(5):1-8.

  3. Rawlings AV, Matts PJ, Anderson CD, Roberts MS. Skin biology, xerosis, barrier repair and measurement. Drug Discov Today. 2008;5(2):e127-36.

  4. Fluhr J, Holleran WM, Berardesca E.. Clinical Effects of Emollients on Skin. In: Leyden JJ, Rawlings AV (eds). Skin moisturization. NY: Marcel Dekker. 2002:223-43.

  5. Rudikoff D. The effect of dryness on the skin. Clinic´s in Dermatol. 1998;16:99-107.

  6. Leyden J. Rawlings A. The skin moisturizer marketplace. In: Leyden J, Rawlings A (eds). Skin Moisturization. NY: Marcel Dekker. 2002:26-55.

  7. Lodén M. The clinical benefit of moisturizers. J Eur Acad Dermatol Venereol. 2005;19(6):672-88.

  8. Barton S. Formulation of Skin Moisturizers. In: Leyden JJ, Rawlings. AV, (eds). Skin Moisturization. NY: Marcel Dekker. 2002: 547-84.

  9. Lodén M, Lindberg M. The influence of a single application of different moisturizers on the skin capacitance. Acta Derm Venereol. 1991;71(1): 79-82.

  10. Buraczewska I, Broström U, Lodén M. Artificial reduction in transepidermal water loss improves skin barrier function. Br J Dermatol. 2007;157(1):82-6.

  11. Berne B, Lindberg M, Törmä H, Lodén M. Changes in skin barrier function following long-term treatment with moisturizers, a randomized controlled trial. Br J Dermatol. 2007; 156(3):492-8.

  12. Grove G. Non invasive Instrumental Methods for Assessing Moisturizers. Skin Moisturization. NY: Marcel Dekker.2002: 499-528.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Gac Med Mex. 2011;147